the Swiss HIV Cohort Study
The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study
Surial B, Wandeler G, Furrer H, Rauch A, Schmid P, Bernasconi E, Stöckle M, Günthard H, Calmy A, Darling K, Daeppen J, Bertholet N, the Swiss HIV Cohort Study. The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study. J Clin Med 2021; 10
14.01.2021The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study
14.01.2021J Clin Med 2021; 10
Surial Bernard, Wandeler Gilles, Furrer Hansjakob, Rauch Andri, Schmid Patrick, Bernasconi Enos, Stöckle Marcel, Günthard Huldrych F, Calmy Alexandra, Darling Katharine E A, Daeppen Jean-Bernard, Bertholet Nicolas, the Swiss HIV Cohort Study
The interplay between host genetic variation, viral replication and microbial translocation in untreated HIV-infected individuals
Perkins M, Fellay J, Douek D, Telenti A, Battegay M, Calmy A, Hoffmann M, Bernasconi E, Hauser C, Günthard H, Wollinsky D, Liebner J, Timmer J, Bartha I, the Swiss HIV Cohort Study. The interplay between host genetic variation, viral replication and microbial translocation in untreated HIV-infected individuals. J Infect Dis 2015
20.02.2015The interplay between host genetic variation, viral replication and microbial translocation in untreated HIV-infected individuals
20.02.2015J Infect Dis 2015
Perkins Molly R, Fellay Jacques, Douek Daniel C, Telenti Amalio, Battegay Manuel, Calmy Alexandra, Hoffmann Matthias, Bernasconi Enos, Hauser Christoph, Günthard Huldrych F, Wollinsky David, Liebner Julia C, Timmer J Katherina, Bartha István, the Swiss HIV Cohort Study
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
Metzner K, Günthard H, Weber R, Bernasconi E, Calmy A, Cavassini M, Vernazza P, Hirsch H, Furrer H, Aubert V, Klimkait T, Yerly S, Böni J, von Wyl V, Scherrer A, the Swiss HIV Cohort Study. Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS 2014; 28:2231-2239.
24.09.2014Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
24.09.2014AIDS 2014; 28:2231-2239
Metzner Karin J, Günthard Huldrych F, Weber Rainer, Bernasconi Enos, Calmy Alexandra, Cavassini Matthias, Vernazza Pietro, Hirsch Hans H, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Scherrer Alexandra U, the Swiss HIV Cohort Study
Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study
Boillat-Blanco N, Cavassini M, Günthard H, Furrer H, Clerc O, Aouri M, Bernasconi E, Fulchini R, Rougemont M, Vuichard D, Schöni-Affolter F, Darling K, the Swiss HIV Cohort Study. Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study. Antivir Ther (Lond) 2014
25.06.2014Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study
25.06.2014Antivir Ther (Lond) 2014
Boillat-Blanco Noémie, Cavassini Matthias, Günthard Huldrych F, Furrer Hansjakob, Clerc Olivier, Aouri Manel, Bernasconi Enos, Fulchini Rosamaria, Rougemont Mathieu, Vuichard Danielle, Schöni-Affolter Franziska, Darling Katharine Ea, the Swiss HIV Cohort Study
Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals
Rohrbach J, Rauch A, Furrer H, Bernasconi E, Ambrosioni J, Cavassini M, Vuichard D, Günthard H, Scherrer A, Kovari H, Thormann W, Schmid P, Stickel F, the Swiss HIV Cohort Study. Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals. Antivir Ther (Lond) 2013
13.09.2013Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals
13.09.2013Antivir Ther (Lond) 2013
Rohrbach Janine, Rauch Andri, Furrer Hansjakob, Bernasconi Enos, Ambrosioni Juan, Cavassini Matthias, Vuichard Danielle, Günthard Huldrych F, Scherrer Alexandra, Kovari Helen, Thormann Wolfgang, Schmid Patrick, Stickel Felix, the Swiss HIV Cohort Study
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir
Young J, Bucher H, Battegay M, Weber R, Cavassini M, Calmy A, Vernazza P, Bernasconi E, Furrer H, Fux C, Schäfer J, the Swiss HIV Cohort Study. Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir. AIDS 2012; 26:567-575.
13.03.2012Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir
13.03.2012AIDS 2012; 26:567-575
Young Jim, Bucher Heiner C, Battegay Manuel, Weber Rainer, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Bernasconi Enos, Furrer Hansjakob, Fux Christoph A, Schäfer Juliane, the Swiss HIV Cohort Study
Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy
Glass T, Marzolini C, Battegay M, Wandeler G, Bernasconi E, Hirschel B, Nicca D, Rickenbach M, Günthard H, Bucher H, Csajka C, Decosterd L, Telenti A, Rotger M, the Swiss HIV Cohort Study. Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy. PloS one 2012; 7:e29186.
03.01.2012Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy
03.01.2012PloS one 2012; 7:e29186
Glass Tracy R, Marzolini Catia, Battegay Manuel, Wandeler Gilles, Bernasconi Enos, Hirschel Bernard, Nicca Dunja, Rickenbach Martin, Günthard Huldrych F, Bucher Heiner C, Csajka Chantal, Decosterd Laurent, Telenti Amalio, Rotger Margalida, the Swiss HIV Cohort Study
Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
Gianella S, Günthard H, Joos B, Weber R, Vernazza P, Hirschel B, Rauch A, Cavassini M, Bernasconi E, Battegay M, Niederoest B, Fischer M, von Wyl V, the Swiss HIV Cohort Study. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Antivir Ther 2011; 16:535-545.
01.01.2011Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
01.01.2011Antivir Ther 2011; 16:535-545
Gianella Sara, Günthard Huldrych F, Joos Beda, Weber Rainer, Vernazza Pietro, Hirschel Bernard, Rauch Andri, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Niederoest Barbara, Fischer Marek, von Wyl Viktor, the Swiss HIV Cohort Study
Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
Lubomirov R, Telenti A, Günthard H, Furrer H, Vernazza P, Elzi L, Bernasconi E, Hirschel B, Cavassini M, Martinez R, Ledergerber B, di Iulio J, Colombo S, the Swiss HIV Cohort Study. Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study. J Infect Dis 2010; 203:246-257.
09.12.2010Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
09.12.2010J Infect Dis 2010; 203:246-257
Lubomirov Rubin, Telenti Amalio, Günthard Huldrych F, Furrer Hansjakob, Vernazza Pietro, Elzi Luigia, Bernasconi Enos, Hirschel Bernard, Cavassini Matthias, Martinez Raquel, Ledergerber Bruno, di Iulio Julia, Colombo Sara, the Swiss HIV Cohort Study
Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy
Bucher H, Battegay M, Weber R, Vernazza P, Schiffer V, Fux C, Cavassini M, Bernasconi E, Vallet Y, Glass T, Young J, Rickenbach M, the Swiss HIV Cohort Study. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antivir Ther 2010; 15:31-40.
01.01.2010Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy
01.01.2010Antivir Ther 2010; 15:31-40
Bucher Heiner C, Battegay Manuel, Weber Rainer, Vernazza Pietro, Schiffer Véronique, Fux Christoph, Cavassini Matthias, Bernasconi Enos, Vallet Yannick, Glass Tracy R, Young Jim, Rickenbach Martin, the Swiss HIV Cohort Study
Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study
Glass T, Bucher H, Günthard H, Rickenbach M, Bernasconi E, Hirschel B, Vernazza P, Furrer H, De Geest S, Cavassini M, Battegay M, the Swiss HIV Cohort Study. Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2009
23.12.2009Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study
23.12.2009Journal of acquired immune deficiency syndromes (1999) 2009
Glass Tracy R, Bucher Heiner C, Günthard Huldrych F, Rickenbach Martin, Bernasconi Enos, Hirschel Bernard, Vernazza Pietro, Furrer Hansjakob, De Geest Sabina, Cavassini Matthias, Battegay Manuel, the Swiss HIV Cohort Study